or Try an Advanced Search...

    Technical Analysis for FHTX - Foghorn Therapeutics Inc.

    Grade Last Price % Change Price Change
    C 8.30 8.92% 0.68
    FHTX closed up 8.92 percent on Friday, November 1, 2024, on 40 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical FHTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Fell Below 20 DMA Bearish 8.92%
    Bollinger Band Squeeze Range Contraction 8.92%
    Earnings Movers Other 8.92%
    50 DMA Resistance Bearish 3.23%
    Bollinger Band Squeeze Range Contraction 3.23%
    Stochastic Reached Overbought Strength 3.23%
    BB Squeeze + Upper Band Touch Range Contraction 3.23%
    Older End-of-Day Signals for FHTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 19 hours ago
    Possible NR7 about 20 hours ago
    Up 5% about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    10 DMA Support about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    FHTX Chart by TradingView
    Basic chart:

    Profile

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication

    Is FHTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
    Oct 11 Foghorn Therapeutics Unveils Clinical Pipeline Progress
    Oct 10 Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors
    Oct 7 BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
    Oct 3 Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
    Oct 1 Foghorn Therapeutics to Participate in the BMO Oncology Summit
    Sep 16 Strength Seen in Foghorn Therapeutics (FHTX): Can Its 9.5% Jump Turn into More Strength?
    Sep 11 Insider Sale: Chief Scientific Officer Steven Bellon Sells 20,000 Shares of Foghorn ...
    Sep 3 Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer
    Sep 2 Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 81.16%: Read This Before Placing a Bet
    See more FHTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.25
    52 Week Low 2.7
    Average Volume 167,895
    200-Day Moving Average 6.49
    50-Day Moving Average 8.35
    20-Day Moving Average 7.70
    10-Day Moving Average 7.80
    Average True Range 0.56
    RSI (14) 54.34
    ADX 16.59
    +DI 22.55
    -DI 18.20
    Chandelier Exit (Long, 3 ATRs) 6.77
    Chandelier Exit (Short, 3 ATRs) 8.63
    Upper Bollinger Bands 8.33
    Lower Bollinger Band 7.06
    Percent B (%b) 0.98
    BandWidth 16.42
    MACD Line -0.06
    MACD Signal Line -0.14
    MACD Histogram 0.0768
    Fundamentals Value
    Market Cap 350.4 Million
    Num Shares 42.2 Million
    EPS -2.46
    Price-to-Earnings (P/E) Ratio -3.37
    Price-to-Sales 8.40
    Price-to-Book 10.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.12
    Resistance 3 (R3) 9.03 8.66 8.98
    Resistance 2 (R2) 8.66 8.46 8.71 8.94
    Resistance 1 (R1) 8.48 8.33 8.57 8.57 8.89
    Pivot Point 8.12 8.12 8.16 8.16 8.12
    Support 1 (S1) 7.94 7.91 8.03 8.03 7.71
    Support 2 (S2) 7.57 7.78 7.62 7.66
    Support 3 (S3) 7.39 7.57 7.62
    Support 4 (S4) 7.48